Neovii Competitors and Similar CompaniesClear all

Neovii's competitors and similar companies include Alpha Tau Medical, Silverback Therapeutics, SQZ Biotech and Foghorn Therapeutics.
Neovii
Neovii
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Alpha Tau Medical
Alpha Tau Medical
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
Silverback Therapeutics
Silverback Therapeutics
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
SQZ Biotech
SQZ Biotech
SQZ Biotech is a company that develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Founding Date
Founding Date
2003
Founding Date
2016
Founding Date
2016
Founding Date
2013
Founding Date
2016
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Rapperswil-Jona, CH HQ
Gräfelfing, DE
Lexington, US
Locations
Tel Aviv-Yafo, IL HQ
Boston, US
Locations
Seattle, US HQ
Locations
Watertown, US HQ
Locations
Cambridge, US HQ
Cambridge, US
Employees
Employees
1001% decrease
Employees
984% increase
Employees
9067% increase
Employees
5353% decrease
Employees
16135% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
206.2 m
Valuation ($)
12.8 m
Valuation ($)
246 m
Twitter followers
Twitter followers
N/A
Twitter followers
949
Twitter followers
206
Twitter followers
714
Twitter followers
1.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
88.89%

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$21.5m (FY, 2022)
Revenue (est.)
$34.2m (FY, 2023)
Net income
Net income
N/A
Net income
N/A
Net income
($89.5m) (FY, 2021)
Net income
($79.5m) (FY, 2022)
Net income
($98.4m) (FY, 2023)

Operating

IND-Enabling Stage Products
IND-Enabling Stage Products
N/A
IND-Enabling Stage Products
N/A
IND-Enabling Stage Products
1 (Q3, 2020)
IND-Enabling Stage Products
N/A
IND-Enabling Stage Products
2 (Q2, 2020)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
1 (Q3, 2020)
Phase I Trials Products
1 (Q2, 2020)
Phase I Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 55m
Total funding raised
$ 211m
Total funding raised
$ 233.4m
Total funding raised
$ 50m
For sources of this data, please see the company profile

View Company Profiles

Alpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
98↑ 4% increase

Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.

View company
Silverback Therapeutics
HQ
Seattle, US
Employees
90

Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.

View company
SQZ Biotech
HQ
Watertown, US
Employees
53

SQZ Biotech is a company that develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions.

View company
Foghorn Therapeutics
HQ
Cambridge, US
Employees
161↑ 35% increase

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

View company